Comparison of neonatal outcomes between multiples and singletons among very low birth weight infants: The Korean Neonatal Network Cohort Study

DOI: https://doi.org/10.21203/rs.3.rs-2173127/v1

Abstract

To compare neonatal outcomes between multiples and singletons among very low birth weight infants (VLBWIs), this was a prospective cohort study that was conducted by collecting data registered in the Korean Neonatal Network (KNN) database from January 2013 to December 2016. There were 8265 infants in the KNN database, and 2958 of them were from a multiple pregnancy (MP VLBWIs). Among them, 2636 infants were twins, 308 infants were triplets, and 14 infants were quadruplets. MP VLBWIs had a higher gestational age, birth weight, Apgar scores at 5 minutes, the rates of caesarean section and artificial reproductive technology (ART) but lower maternal hypertension, oligohydramnios, chorioamnionitis rates and CRIB scores than the singleton VLBWIs (SG VLBWIs). In univariate analysis, the MP VLBWIs had a lower incidence of respiratory distress syndrome, bronchopulmonary dysplasia, and sepsis, but the mortality rate was not significantly different for overall gestational ages except born at ≤ 26 weeks of gestation. In multivariate logistic analysis, the incidences of intraventricular haemorrhage (grade ≥ 3), and retinopathy of prematurity requiring treatment were significantly higher than the SG VLBWIs. A new strategy to improve the mortality of immature MP VLBWIs born at ≤ 26 weeks of gestation should be developed.

Introduction

The number of multiple pregnancies has been increasing mainly in developed countries due to the increase in assisted reproductive technology (ART), including in vitro fertilization, and the increased reproductive age of mothers. In 2018, 33.5 of every 1000 births in the United States were multiple births1. In Korea, the multiple birth rate also increased from 10.0 to 27.5 per 1000 births between 1991 and 20082, and from 2009 to 2015, the birth rate of twins and triplets increased by 34.5% and 154.3%, respectively3.

Multiple pregnancies are risk factors for pregnancy complications such as preeclampsia, preterm premature rupture of membranes (PPROM), premature birth, intrauterine growth restriction (IUGR) and foetal death35. Preterm infants, particularly those with a very low birth weight (VLBW), are a major risk factor for neonatal outcomes associated with multiple

pregnancies. One-third of the VLBWIs admitted to the neonatal intensive care unit (NICU) were multiples in Spain6. In addition, it has been reported that multiple pregnancy has a high incidence of congenital anomalies and lower efficacy of antenatal steroids7,8. Risk factors for multiple foetuses are the basis for foetal reduction and selective termination during in vitro fertilization9,10.

Although several studies have reported that these risk factors for multiple pregnancies lead to worse neonatal outcomes in multiples than in singletons4,11,12, it was recently reported that the neonatal outcomes of multiples are similar to those of singletons13.

Therefore, the purpose of this study was to analyse the neonatal mortality and morbidity of multiple VLBWIs compared to those of singleton VLBWIs using a recent large cohort of infants from the Korean Neonatal Network (KNN) database.

Results

A total of 8265 infants were included, of which 2958 (35.8%) were from a multiple pregnancy. Of the 2958 MP VLBWIs, 2636 (89.1%) infants were twins, 308 (10.4%) infants were triplets, and 14 (0.5%) infants were quadruplets.

The mean GA (29+ 2 weeks vs. 28+ 4 weeks; P < 0.001) and mean BW (1150 g vs. 1100 g; P < 0.001) were higher in the MP group than in the SG group. The incidences of an Apgar score of ≥ 7 at 5 minutes, caesarean section, and IVF were significantly higher in the MP group than in the SG group. Among the 1564 MP infants (52.9%) conceived by IVF, 1344 (85.9%) were twins, 213 (13.6%) were triplets, and 7 (0.4%) were quadruplets. In contrast, the incidence of male sex, maternal HTN, oligohydramnios, chorioamnionitis, and a CRIB score of ≥ 8 was significantly lower in the MP group than in the SG group. There were no significant differences between groups in the incidence of transfers, maternal DM, PROM, antenatal steroid use, or major congenital defects (Table 1).

Table 1

Demographic characteristics of multiples versus singletons among VLBWIs

 

Singletons

(N = 5307)

Multiples

(N = 2958)

P value

Gestational age (weeks)

28+ 4 [26+ 4, 30+ 4]

29+ 2 [26+ 6, 31+ 1]

< 0.001

Birth weight (g)

1100 [850, 1310]

1150 [880, 1354]

< 0.001

Apgar score at 5 minutes (≥ 7)

3356 (63.2%)

2010 (68.0%)

< 0.001

Male sex

2716 (51.2%)

1444 (48.8%)

0.042

Outborn birth

180 (3.4%)

96 (3.2%)

0.771

Caesarean section

3892 (73.3%)

2499 (84.5%)

< 0.001

IVF

336 (6.3%)

1564 (52.9%)

< 0.001

Maternal HTN

1386 (26.1%)

308 (10.4%)

< 0.001

Maternal DM

439 (8.3%)

260 (8.8%)

0.442

PROM

1914 (36.1%)

1002 (33.9%)

0.053

Oligohydramnios

815 (15.4%)

283 (9.6%)

< 0.001

Chorioamnionitis

1716 (32.3%)

648 (21.9%)

< 0.001

Antenatal steroid use

4043 (76.2%)

2272 (76.8%)

0.405

Major congenital defect

199 (3.7%)

98 (3.3%)

0.337

CRIB score (≥ 8)

2020 (38.1%)

866 (29.3%)

< 0.001

Values are expressed as the mean [minimum value, maximum values] or as the number (percentage) of patients. VLBWI, very low birth weight infant; IVF, in vitro fertilization; HTN, hypertension; DM, diabetes mellitus; PROM, premature rupture of membranes; CRIB, Clinical Risk Index for Babies.

When comparing morbidity and mortality, the incidence of RDS was significantly lower in the MP group than in the SG group according to overall GA. The incidence of RDS was not significantly different between the two groups at ≤ 32 weeks of gestation but was significantly decreased in the MP group in the ≥ 33 weeks category. The incidence of PDA requiring surgery was not significantly different between groups at any GA; however, there was a significant increase in the MP group at 29–30 weeks of gestation. BPD and sepsis were significantly decreased in the MP group, but there was no significant difference in the incidence according to the GA category. The incidence of IVH, NEC, and ROP requiring treatment did not differ significantly between these groups across any GA categories. Mortality was not significantly different between these groups according to overall gestational age, except for a significant increase in the MP group at ≤ 26 weeks of gestation (Table 2).

Table 2

Morbidity and mortality of multiples versus singletons among VLBWIs

 

≤ 26 weeks

27–28 Weeks

29–30 Weeks

31–32 Weeks

≥ 32 Weeks

Total

 

Singleton

(N = 359)

MP

(N = 196)

Singleton

(N = 398)

MP

(N = 147)

Singleton

(N = 483)

MP

(N = 255)

Singleton

(N = 474)

MP

(N = 311)

Singleton

(N = 367)

MP

(N = 247)

Singleton

(N = 5307)

MP

(N = 2958)

RDS

352 (98.1%) vs. 192 (98.0%)

378 (95.0%) vs. 143 (97.3%)

425 (88.0%) vs. 220 (86.3%)

289 (61.0%) vs. 199 (64.0%)

113 (30.8%) vs. 56 (22.7%)*

4239 (79.9%) vs. 2218 (75.0%)*

PDA Op

84 (23.4%) vs. 44 (22.4%)

64 (16.1%) vs. 27 (18.4%)

28 (5.8%) vs. 28 (11.0%)*

9 (1.9%) vs. 12 (3.9%)

8 (2.2%) vs. 2 (0.8%)

582 (11.0%) vs. 298 (10.1%)

BPD

160 (44.6%) vs. 58 (29.6%)

139 (34.9%) vs. 54 (36.7%)

129 (26.7%) vs. 66 (25.9%)

67 (14.1%) vs. 58 (18.6%)

21 (5.7%) vs. 18 (7.3%)

1447 (27.3%) vs. 679 (23.0%)*

Sepsis

143 (39.9%) vs. 67 (34.2%)

110 (27.6%) vs. 50 (34.0%)

82 (17.0%) vs. 36 (14.1%)

54 (11.4%) vs. 28 (9.0%)

28 (7.6%) vs. 15 (6.1%)

1154 (21.7%) vs. 562 (19.0%)*

IVH (grade ≥ 3)

95 (26.5%) vs. 61 (31.1%)

31 (7.8%) vs. 13 (8.8%)

21 (4.3%) vs. 17 (6.7%)

11 (2.3%) vs. 7 (2.3%)

6 (1.6%) vs. 0 (0.0%)

476 (9.0%) vs. 289 (9.8%)

NEC (stage ≥ 2)

56 (15.6%) vs. 30 (15.3%)

29 (7.3%) vs. 17 (11.6%)

20 (4.1%) vs. 14 (5.5%)

10 (2.1%) vs. 8 (2.6%)

11 (3.0%) vs. 6 (2.4%)

369 (7.0%) vs. 181 (6.1%)

ROP Tx

84 (23.4%) vs. 47 (24.0%)

34 (8.5%) vs. 18 (12.2%)

13 (2.7%) vs. 8 (3.1%)

0 (0.0%) vs. 3 (1.0%)

0 (0.0%) vs. 0 (0.0%)

400 (7.5%) vs. 240 (8.1%)

Mortality

142 (39.6%) vs. 100 (51.0%)*

66 (16.6%) vs. 19 (12.9%)

20 (4.1%) vs. 14 (5.5%)

21 (4.4%) vs. 12 (3.9%)

8 (2.2%) vs. 4 (1.6%)

731 (13.8%) vs. 404 (13.7%)

Values are expressed as the number (percentage) of patients. An asterisk (*) indicates that the value of the multiple (MP) group was significantly different from that of the singleton group (P < 0.005).
VLBWI, very low birth weight infant; RDS, respiratory distress syndrome; PDA, patent ductus arteriosus; Op, operation; BPD, bronchopulmonary dysplasia; IVH, intraventricular haemorrhage; NEC, necrotizing enterocolitis; ROP, retinopathy of prematurity; Tx, treatment

In multivariate logistic regression analysis, the risk of IVH (OR, 1.74; 95% CI, 1.23–2.47; P = 0.002) and ROP requiring treatment (OR, 1.41; 95% CI, 1.01–1.97; P = 0.041) was significantly higher in the MP group than in the SG group (Table 3).

Table 3

Adjusted odds ratios of mortality and major morbidities of multiples versus singletons among VLBWIs

 

Odds ratio

95% Confidence interval

P value

RDS

0.75

0.54–1.04

0.081

PDA Op

1.03

0.76–1.40

0.852

BPD

1.06

0.84–1.35

0.622

Sepsis

1.13

0.88–1.46

0.343

IVH (grade ≥ 3)

1.74

1.23–2.47

0.002

NEC (stage ≥ 2)

1.19

0.78–1.79

0.402

ROP Tx

1.41

1.01–1.97

0.041

Mortality

1.42

0.55–3.40

0.448

VLBWI, very low birth weight infant; RDS, respiratory distress syndrome; PDA, patent ductus arteriosus; Op, operation; BPD, bronchopulmonary dysplasia; IVH, intraventricular haemorrhage; NEC, necrotizing enterocolitis; ROP, retinopathy of prematurity; Tx, treatment

Discussion

Compared to SG infants, MP infants have historically been considered to have increased risk of perinatal mortality and morbidity, primarily because of higher rates of preterm birth and low BW1416. Although worse neonatal outcomes for MP infants have been seen at extremely low gestational age in several studies4,11,12,17,18, some recent studies have reported that neonatal outcomes for MP infants are comparable to those for SG infants13,19. In this study, the mortality rate of extremely premature MP infants born at ≤ 26 weeks of gestation was higher than that of SG infants in univariate analysis. This result is similar to the report of Shinwell20, but MP was not an independent risk factor for mortality in multivariate analysis. However, there was a statistically significant increase in IVH grades ≥ 3 (OR = 1.74, 95% CI 1.23–2.47, p = 0.002) and ROP requiring treatment (OR = 1.41, 95% CI 1.01–1.97, p = 0.041) in MP infants. This is different from some reports that abnormalities shown on brain ultrasound are not high in VLBWIs born through IVF21,22. Heo22 et al. suggested that pregnant women with VLBWIs who were conceived through IVF had relatively high socioeconomic status, suggesting the possibility that their prenatal management was more thorough. However, as a result of the analysis with multiples and singletons, including those conceived by both IVF and natural pregnancy, epidemiological differences, such as those in GA, BW, and 5-min Apgar scores, were more favourable in the MG group than in the SG group, and these results were inconsistent in these aspects. One of the causes of increased IVH may be differences in blood pressure between singletons and multiples23 and some qualitative differences in early resuscitation by experienced medical faculty on in neonatal resuscitation program (NRP) teams. It cannot be excluded that the number of NRP team members caring for VLBWIs shortly after birth and the qualitative differences in procedures may differ between MG infants and SG infants. As reported in the paper, the prognosis differs depending on the number and skill level of the medical staff participating in delivery24, and NRP teams may require at least 4 or more neonatal medical personnel per VLBWI to participate in the preparation for one newborn at a time. It is considered that there is a difference in the prognosis between VLBWIs born in hospitals where well-trained faculty members can attend every birth and VLBWIs who do not. However, the difference in these conditions was not included in the national data provided in this paper, so it was difficult to analyse, and more research is needed.

The incidence of ROP is generally known to increase with the use of excess oxygen25,26. However, according to the results of this study, when the RDS, BPD, and sepsis rates were significantly reduced in the MG group, the increase in ROP requiring treatment was considered meaningful. Considering this, the vascular growth abnormality itself in multiples and the difference in vascular growth factors can be considered27. Kistner et al.27 reported high blood pressure in infants with severe ROP. In addition, as a factor that can vary depending on the individual tendency of an ophthalmologist to screen for and treat ROP, differences between institutions can be considered28.

In the MP VLBWIs, maternal hypertension was low, caesarean section delivery was more frequent, and as expected, there was an increase in the number of pregnancies conceived through IVF. The rates of chorioamnionitis and oligohydramnios at birth were significantly lower, and the number of infants with CRIB scores ≥ 8 were lower in MP VLBWIs than SG VLBWIs. It is possible that the conditions of the foetuses were relatively good in the MP VLBWIs, as much attention and medical care were provided to the mothers29. These cautious antenatal cares may have contributed to the lower rate of RDS, BPD, and sepsis in the MP VLBWIs compared to the SG VLBWIs, and the results were different from other studies30 reporting that the prognosis of multiples and singletons was similar.

In the analysis of all GAs, the frequency of PDA ligation was increased in the MG VLBWIs compared to the SG VLBWIs at 29–32 weeks of gestation and was significantly increased at 29–30 weeks of gestational age. Margaryan et al.31 reported that the average age of VLBWIs requiring surgical treatment was 29.1 weeks of gestation, which is consistent with the age of surgery confirmed in this study. More research is needed on the increase in surgical treatment rates in MG VLBWIs.

A limitation of the study was that it was not possible to analyse the differentiation between units such as in medical resources, decision-making processes, and medical faculties including quality and numbers. Therefore, further studies on these issues should be conducted in the future.

Henceforth, new strategies should be developed to improve the mortality rate of premature infants born at ≤ 26 weeks of gestation. Therefore, in women with MP pregnancy, who are expected to give birth extremely prematurely, more intensive prenatal management, such as antenatal steroid administration and planned delivery, should be performed. In addition, to reduce the frequency of IVH and ROP requiring treatment for MP VLBWIs, the cause should be identified, and a strategy should be established.

This study aimed to investigate neonatal mortality and morbidity in MP VLBWIs compared with those of SG VLBWIs in Korea. We found that mortality was not significantly different between MP and SG infants according to overall gestational age, except for a significant increase in MP VLBWIs born at ≤ 26 weeks and a significantly higher risk of IVH and ROP requiring treatment in the MP group. To our knowledge, this study is the first domestic study to evaluate neonatal mortality and morbidity in MP VLBWIs compared with those in SG VLBWIs using a large population-based study in Korea. In addition, close observation and an appropriate response to symptomatic PDA are necessary in MG VLBWIs born between 29–30 weeks of gestation.

Methods

Study population

This study used data from the KNN obtained from 67 neonatal intensive care units (NICUs) during the period of January 2013 to December 2016. Data for VLBWIs who were born in the KNN’s participating NICUs or transferred within 28 days of birth were prospectively enrolled. The included infants were divided into the singleton group (SG) and the multiple group (MP). Each of these groups was divided into 5 categories according to gestational age (GA): ≤26 weeks, 27–28 weeks, 29–30 weeks, 31–32 weeks, and ≥ 33 weeks. All methods were performed in accordance with the relevant guidelines and regulations.

Data analysis

We compared maternal and neonatal variables, including gestational age (GA), birth weight (BW), sex, transfer after birth, mode of delivery, in vitro fertilization (IVF), maternal hypertension (HTN), prenatal steroid use, maternal diabetes mellitus (DM), premature rupture of membranes (PROM), oligohydramnios, pathological chorioamnionitis, an Apgar score of ≥ 7 at 5 minutes, major congenital defects, and a Clinical Risk Index for Babies (CRIB) score of ≥ 8, between the SG and MP groups.

We also compared mortality and major morbidities, such as respiratory distress syndrome (RDS), patent ductus arteriosus (PDA) requiring surgery, moderate to severe bronchopulmonary dysplasia (BPD), sepsis, necrotizing enterocolitis (NEC) with a modified Bell’s stage above II, severe intraventricular haemorrhage (IVH) with a Papile’s grade above 3, and retinopathy of prematurity (ROP) requiring treatment, between the SG and MP groups grouped by GA.

Definitions

Multiple pregnancy was defined as the presence of two or more embryos in the uterus by spontaneous pregnancy, ovulation-induction therapy, or the use of ART methods. PROM was defined as rupture of the membrane more than 24 hours before the onset of labour. Maternal HTN included preeclampsia, eclampsia, and chronic hypertension. Maternal DM included overt and gestational DM.

The CRIB score is based on GA, BW, the presence or absence of congenital malformations, the maximum base excess, and the minimum and maximum appropriate fraction of inspired oxygen during the first 12 hours of life32. RDS was defined as dyspnoea that was diagnosed based on chest radiography and clinical symptoms and required respiratory support with surfactant therapy. BPD was defined as the need for supplemental oxygen support at 36 weeks PMA33. Sepsis was defined according to the Centers for Disease Control and Prevention/National Nosocomial Infection Surveillance (NNIS) definitions for infants ≤ 12 months of age34. NEC was defined as radiographic evidence of pneumatosis intestinalis or intestinal perforation or the need for surgery with a confirmed diagnosis at the time of surgery (Bell’s stages II and III)35. Grade 3 or 4 IVH was defined using Papile’s criteria36. ROP was defined as a disorder of retinal blood vessel development in premature infants and was classified using the International Classification for ROP. The suggested treatment indications were any stage plus disease or stage 3 in zone I ROP and stages 2 or 3 with disease in zone II ROP. Treatment for ROP included surgery (e.g., cryotherapy, laser photocoagulation and/or vitrectomy) and/or intravitreal injection with antivascular endothelial growth factor (anti-VEGF) agents37.

Statistical analysis

Continuous variables are presented as the mean (± standard deviation [SD]) or median [25 percentiles, 75 percentiles]. Categorical variables are presented as percentages in tabulations. Categorical variables were compared between the two groups using either the chi-squared test or Fisher’s exact test. Continuous variables were compared using either Student’s t test or the Kruskal–Wallis rank-sum test. In each GA group (≤ 26 weeks, 27–28 weeks, 29–30 weeks, 31–32 weeks, and ≥ 33 weeks), survival and morbidity were calculated, and multivariate logistic regression was performed to obtain the adjusted odds ratios(ORs) of mortality and morbidity between the MP and SG groups. ORs with 95% confidence intervals (CIs) were used to test morbidity and mortality between the MP and SG groups. Statistical significance was set at P < 0.05. All statistical analyses were performed using R software (R Foundation for Statistical Computing, Vienna, Austria)38

Data availability

All the data generated and/or analysed during the current study are included in this article and are available from the corresponding author on reasonable request.

Statement of Ethics

The KNN data registry was approved by the institutional review board of all hospitals in each participating centre during admission and follow-up, and written informed consent was obtained from the parents of infants at enrolment in the KNN. All methods were performed in accordance with the relevant guidelines and regulation.

The names of the institutional review board of the KNN participating hospitals were as follows: The institutional review board of Gachon University Gil Medical Center, The Catholic University of Korea Bucheon ST. Mary’s Hospital, The Catholic University of Korea Seoul ST. Mary’s Hospital, The Catholic University of Korea ST. Vincent’s Hospital, The Catholic University of Korea Yeouido ST. Mary’s Hospital, The Catholic University v of Korea Uijeongbu ST. Mary’s Hospital, Gangnam Severance Hospital, Kyung Hee University Hospital at Gangdong, GangNeung Asan Hospital, Kangbuk Samsung Hospital, Kangwon National University Hospital, Konkuk University Medical Center, Konyang University Hospital, Kyungpook National University Hospital, Gyeongsang National University Hospital, Kyung Hee University Medical Center, Keimyung University Dongsan Medical Center, Korea University Guro Hospital, Korea University Ansan Hospital, Korea University Anam Hospital, Kosin University Gospel Hospital, National Health Insurance Service Iilsan Hospital, Daegu Catholic University Medical Center, Dongguk University Ilsan Hospital, Dong-A University Hospital, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Pusan National University Hospital, Busan ST Mary’s Hospital, Seoul National University Bundang Hospital, Samsung Medical Center, Samsung Changwon Medical Center, Seoul National University Hospital, Asan Medical Center, Sungae Hospital, Severance Hospital, Soonchunhyang University Hospital Bucheon, Soonchunhyang University Hospital Seoul, Soonchunhyang University Hospital Cheonan, Ajou University Hospital, Pusan National University Children’s Hospital, Yeungnam University Hospital, Ulsan University Hospital, Wonkwang University School of Medicine & Hospital, Wonju Severance Christian Hospital, Eulji University Hospital, Eulji General Hospital, Ewha Womans University Medical Center, Inje University Busan Paik Hospital, Inje University Sanggye Paik Hospital, Inje University Ilsan Paik Hospital, Inje University Haeundae Paik Hospital, Inha University Hospital, Chonnam National University Hospital, Chonbuk National University Hospital, Cheil General Hospital & Women’s Healthcare Center, Jeju National University Hospital, Chosun University Hospital, Chung-Ang University Hospital, CHA Gangnam Medical Center, CHA University, CHA Bundang Medical Center, CHA University, Chungnam National University Hospital, Chungbuk National University, Kyungpook National University Chilgok Hospital, Kangnam Sacred Heart Hospital, Kangdong Sacred Heart Hospital, Hanyang University Guri Hospital, and Hanyang University Medical Center.

Declarations

Acknowledgements

We thank all patients for their generous contributions. We also thank the members of the Korean Neonatal Network (KNN). 

Author Contributions

J.H.L, J.H.H, H.G.J, and S.C. conceptualized, designed, investigated and conducted research and wrote manuscripts. O.K.N., J.H.L, J.H.H., H.G.J. and S.C. formally analysed the data, and J.H.L, J.H.H. critically reviewed and supervised the manuscript. All authors approved the final version of the manuscript.

Additional information

Competing of interests

The authors declare no competing interests.

References

  1. Hamilton, B. E., Martin, J. A., Osterman, M. J., Curtin, S. C. & Matthews, T. J. Births: final data for 2014. Natl. Vital Stat. Rep. 64, 1–64 (2015).
  2. Park, Y. S. et al. Multiple births conceived by assisted reproductive technology in Korea. Korean J. Pediatr. 53, 880–885 (2010).
  3. Ko, H. S. et al. Multiple birth rates of Korea and fetal/neonatal/infant mortality in multiple gestation. PLoS One 13, e0202318 (2018).
  4. Garite, T. J., Clark, R. H., Elliott, J. P. & Thorp, J. A. Twins and triplets: the effect of plurality and growth on neonatal outcome compared with singleton infants. Am. J. Obstet. Gynecol. 191, 700–707 (2004).
  5. Luke, B. & Brown, M. B. Maternal morbidity and infant death in twin vs triplet and quadruplet pregnancies. Am. J. Obstet. Gynecol. 198, 401.e401-410 (2008).
  6. Porta, R. et al. Morbidity and mortality of very low birth weight multiples compared with singletons. J. Matern. Fetal Neonatal Med. 32, 389–397 (2019).
  7. Shinwell, E. S. & Eventov-Friedman, S. Impact of perinatal corticosteroids on neuromotor development and outcome: review of the literature and new meta-analysis. Semin. Fetal Neonatal Med. 14, 164–170 (2009).
  8. Dalziel, S. R. et al. Long term effects of antenatal betamethasone on lung function: 30 year follow up of a randomised controlled trial. Thorax 61, 678–683 (2006).
  9. Ogilvie, C. M. Multiple pregnancy, fetal reduction and selective termination. Reprod. BioMed Online 26, 522–524 (2013).
  10. Tse, W. T., Law, L. W., Sahota, D. S., Leung, T. Y. & Cheng, Y. K. Triplet pregnancy with fetal reduction: experience in Hong Kong. Hong Kong Med. J. 23, 326–332 (2017).
  11. Papiernik, E. et al. Differences in outcome between twins and singletons born very preterm: results from a population-based European cohort. Hum. Reprod. 25, 1035–1043 (2010).
  12. Petit, N., Cammu, H., Martens, G. & Papiernik, E. Perinatal outcome of twins compared to singletons of the same gestational age: a case-control study. Twin Res. Hum. Genet. 14, 88–93 (2011).
  13. Yeo, K. T. et al. Trends in morbidity and mortality of extremely preterm multiple gestation newborns. Pediatrics 136, 263–271 (2015).
  14. Keith, L. G., Oleszczuk, J. J. & Keith, D. M. Multiple gestation: reflections on epidemiology, causes, and consequences. Int. J. Fertil. Womens Med. 45, 206–214 (2000).
  15. Rand, L., Eddleman, K. A. & Stone, J. Long-term outcomes in multiple gestations. Clin. Perinatol. 32, 495–513, viii (2005).
  16. Imaizumi, Y. & Hayakawa, K. Infant mortality among singletons and twins in Japan during 1999–2008 on the basis of risk factors. Twin Res. Hum. Genet. 16, 639–644 (2013).
  17. Donovan, E. F. et al. Outcomes of very low birth weight twins cared for in the National Institute of Child Health and Human Development Neonatal Research Network's intensive care units. Am. J. Obstet. Gynecol. 179, 742–749 (1998).
  18. Shinwell, E. S., Blickstein, I., Lusky, A. & Reichman, B. Excess risk of mortality in very low birthweight triplets: a national, population based study. Arch. Dis. Child. Fetal Neonatal Ed. 88, F36-F40 (2003).
  19. Ray, B. & Platt, M. P. Mortality of twin and singleton livebirths under 30 weeks' gestation: a population-based study. Arch. Dis. Child. Fetal Neonatal Ed. 94, F140-F143 (2009).
  20. Shinwell, E. S. Neonatal morbidity of very low birth weight infants from multiple pregnancies. Obstet. Gynecol. Clin. North Am. 32, 29–38, viii (2005).
  21. Stewart, J. E. et al. Risk of cranial ultrasound abnormalities in very-low-birth-weight infants conceived with assisted reproductive techniques. J. Perinatol. 22, 37–45 (2002).
  22. Heo, J. S., Lee, H. J., Lee, M. H. & Choi, C. W. Comparison of neonatal outcomes of very low birth weight infants by mode of conception: in vitro fertilization versus natural pregnancy. Fertil. Steril. 111, 962–970 (2019).
  23. Vesoulis, Z. A. et al. Blood pressure extremes and severe IVH in preterm infants. Pediatr. Res. 87, 69–73 (2020).
  24. de Graaf, J. P. et al. Increased adverse perinatal outcome of hospital delivery at night. BJOG 117, 1098–1107 (2010).
  25. Tokuhiro, Y. et al. Reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity in infants of < 33 weeks gestation. Pediatr. Int. 51, 804–806 (2009).
  26. Hellstrom, A., Smith, L. E. & Dammann, O. Retinopathy of prematurity. Lancet 382, 1445–1457 (2013).
  27. Kistner, A. et al. Neonatal IGF-1/IGFBP-1 axis and retinopathy of prematurity are associated with increased blood pressure in preterm children. Acta Paediatr. 103, 149–156 (2014).
  28. Austeng, D., Kallen, K. B., Ewald, U. W., Jakobsson, P. G. & Holmstrom, G. E. Incidence of retinopathy of prematurity in infants born before 27 weeks' gestation in Sweden. Arch. Ophthalmol. 127, 1315–1319 (2009).
  29. Dafallah, S. E. & Yousif, E. M. A comparative study of twin and triplet pregnancy. Saudi Med. J. 25, 502–506 (2004).
  30. Ballabh, P. et al. Neonatal outcome of triplet versus twin and singleton pregnancies: a matched case control study. Eur. J. Obstet. Gynecol. Reprod. Biol. 107, 28–36 (2003).
  31. Margaryan, R., Arcieri, L. & Murzi, B. Surgical closure of PDA in low-weight premature infants. J. Matern. Fetal Neonatal Med. 22 Suppl 3, 81–84 (2009).
  32. The CRIB (clinical risk index for babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. The International Neonatal Network. Lancet 342, 193–198 (1993).
  33. Ehrenkranz, R. A. et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 116, 1353–1360 (2005).
  34. Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C. & Hughes, J. M. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control 16, 128–140 (1988).
  35. Walsh, M. C. & Kliegman, R. M. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr. Clin. N. Am. 33, 179–201 (1986).
  36. Papile, L. A., Burstein, J., Burstein, R. & Koffler, H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J. Pediatr. 92, 529–534 (1978).
  37. Fierson, W. M., American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus & American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 142, e20183061 (2018).
  38. R Development Core Team. R: a language and environment for the statistical computing (R Foundation for Statistical Computing, 2017).